Biosimilars: Some Patient And Prescriber Groups Appear To Warm Up To Arbitrary Suffixes
• By Michael Cipriano
The US FDA has approved 20 biosimilars, all but one with an arbitrary suffix. Some patient and prescriber groups are now warming up to the nomencature.
